Real-world off-label apixaban dosing and clinical outcomes in patients with heart failure and end-stage kidney disease. - Im SI; Bae SH; Kim SJ; Kim BJ; Heo JH; Kim YN; Jung Y; Rim H; Cho SP; Park JH; Shin HS (Medicine, 2026)